Key result
Adipose-specific ATRAP downregulation fails to influence dietary obesity or metabolic disorders in mice.
Why the study?
Does adipose tissue-specific ATRAP downregulation influence the development of diet-induced obesity and metabolic disorders in mice?
Does adipose tissue-specific ATRAP downregulation influence the development of diet-induced obesity and metabolic disorders in mice?
Downregulation of ATRAP in brown adipose tissue does not influence the development of dietary obesity or metabolic disorders in mice fed a high-fat diet.
Answers are grounded in this paper and cite their sources.
Null finding in murine brown fat cautions against ATRAP-targeted obesity therapies; leaves open roles in other depots or humans.
Activation of tissue renin–angiotensin system (RAS), mainly mediated by an angiotensin II (Ang II) type 1 receptor (AT1R), plays an important role in the development of obesity-related metabolic disorders. We have shown that AT1R-associated protein (ATRAP), a specific binding protein of AT1R, functions as an endogenous inhibitor to prevent excessive activation of tissue RAS. In the present study, we newly generated ATRAP/Agtrap-floxed (ATRAPfl/fl) mice and adipose tissue-specific ATRAP downregulated (ATRAPadipoq) mice by the Cre/loxP system using Adipoq-Cre. Using these mice, we examined the functional role of adipose ATRAP in the pathogenesis of obesity-related metabolic disorders. Compared with ATRAPfl/fl mice, ATRAPadipoq mice exhibited a decreased ATRAP expression in visceral white adipose tissue (WAT) and brown adipose tissue (BAT) by approximately 30% and 85%, respectively. When mice were fed a high-fat diet, ATRAPfl/fl mice showed decreased endogenous ATRAP expression in WAT that was equivalent to ATRAPadipoq mice, and there was no difference in the exacerbation of dietary obesity and glucose and lipid metabolism. These results indicate that ATRAP in BAT does not influence the pathogenesis of dietary obesity or metabolic disorders. Future studies that modulate ATRAP in WAT are necessary to assess its in vivo functions in the development of obesity-related metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Ohki et al. (2017) studied Diet-induced metabolic disorders. Adipose tissue-specific ATRAP downregulation vs. ATRAPfl/fl mice was evaluated on Exacerbation of dietary obesity and glucose and lipid metabolism. Adipose tissue-specific ATRAP downregulation in brown adipose tissue did not influence the pathogenesis of dietary obesity or metabolic disorders in mice fed a high-fat diet.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: